Eagle Pharmaceuticals Inc sell Piper Sandler
Start price
09.08.23
/
50%
€17.90
Target price
09.08.24
-
Performance (%)
-79.55%
End price
10.08.24
€3.66
Summary
This prediction ended on 10.08.24 with a price of €3.66. The SELL prediction by Piper_Sandler for Eagle Pharmaceuticals Inc performed very well with a performance of -79.55%. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Eagle Pharmaceuticals Inc | - | - | - |
| iShares Core DAX® | 1.014% | 2.699% | 4.363% |
| iShares Nasdaq 100 | -6.470% | -8.771% | 18.004% |
| iShares Nikkei 225® | -6.517% | -12.580% | 40.915% |
| iShares S&P 500 | -2.721% | -1.752% | 16.966% |
Comments by Piper_Sandler for this prediction
In the thread Eagle Pharmaceuticals Inc diskutieren
Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) was downgraded by analysts at Piper Sandler from a "neutral" rating to an "underweight" rating.
Ratings data for EGRX provided by MarketBeat
In the thread Trading Eagle Pharmaceuticals Inc
Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten